endostar protein

05/28/2014 - "Ultrasonic cavitation with Endostar-MB demonstrated a significantly greater inhibition of tumor blood flow on day 7 and tumor growth on day 16 compared with naked MB and control groups. "
06/01/2019 - "These results suggested that blood perfusion showed improvement with whole-tumor perfusion CT using texture analysis in patients with stage IIIA/B NSCLC treated by Endostar."
08/01/2012 - "Moreover, MET CPA combined with Endostar further reduced the frequency of peripheral blood CECs, the value of MVD, and pericyte coverage, with concomitant delay in tumor growth and extension of mouse survival. "
01/01/2015 - "In the present study, we reported for the first time that Endostar combined with L1-10 had significant synergistic effects on the formation of MPE and tumor growth. "
05/24/2010 - "The present study mainly aimed to investigate the direct effects of Endostar (ES) on the proliferation and radiosensitivity of human lung squamous cancer cell line H-520. "

11/01/2015 - "The present study investigated whether the enhanced antitumor effects of Endostar in combination with radiation involved changes in the metabolism and microenvironment in non-small cell lung cancer. "
10/01/2016 - "Endostar as a specific drug in treatment of the nonsmall cell lung cancer is produced using Escherichia coli expression system. "
03/10/2015 - "The therapeuatic effect of Endostar on soft carotid plaque neovascularization in patients with non-small cell lung cancer."
05/20/2009 - "[Endostar Combined GC in the Treatment of Advanced Non-small Cell Lung Cancer.]."
12/01/2011 - "[Efficacy of endostar combined with chemotherapy in multi-cycle treatment of patients with advanced non-small cell lung cancer]."

01/01/2022 - "Notably, the combination of HT001 with Endostar not only significantly reduced ascites production but also prolonged survival of H22 ascites-bearing mice. "
06/01/2015 - "Endostar inhibits ascites formation and prolongs survival in mouse models of malignant ascites."
07/01/2010 - "Continuous intraperitoneal injection can be the optimal means for endostar administration for treatment of malignant ascites."
01/01/2023 - "The clinical treatment of malignant pleural effusion and ascites can be improved by combining pseudomonas aeruginosa injection with endostar. "
06/01/2015 - "In order to determine whether Endostar can suppress the formation of ascites and prolong survival times, mouse models of malignant ascites were established using S180 and H22 tumor cells. "

10/01/2017 - "Many studies have investigated the efficacy of Endostar combined with transcatheter arterial chemoembolization (TACE) versus TACE alone for hepatocellular carcinoma (HCC). "
12/01/2008 - "The aim of this study was to explore the contribution of different doses of Endostar (endostatin, YH-16) on autophagic death in human hepatocellular carcinoma cells. "
10/01/2017 - "Systematic Review and Meta-analysis of Endostar Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Hepatocellular Carcinoma."
08/01/2015 - "Moreover, Endostar can potentiate the inhibition effect of Fv-LDP on the growth of human hepatoma cells and xenografts. "
08/01/2015 - "In vivo, Fv-LDP/Endostar combination showed a significantly synergistic effect on the growth of a human hepatoma xenograft, with an inhibition rate of 80.8% compared with the Fv-LDP (44.1%) or Endostar (8.9%)-treated group. "

11/01/2012 - "Antitumor activity of Endostar combined with radiation against human nasopharyngeal carcinoma in mouse xenograft models."
07/29/2022 - "Efficacy of concurrent chemoradiotherapy plus Endostar compared with concurrent chemoradiotherapy in the treatment of locally advanced nasopharyngeal carcinoma: a retrospective study."
11/01/2021 - "Long-term efficacy and adverse reactions of IMRT combined with Endostar versus IMRT combined with chemotherapy for locally advanced nasopharyngeal carcinoma: a retrospective study."
10/20/2015 - "The efficacy and safety of Endostar combined with chemoradiotherapy for patients with advanced, locally recurrent nasopharyngeal carcinoma."
02/01/2011 - "The inhibitory effects of Endostar in combination with radiotherapy in BALB/c nude mice model of human CNE2 nasopharyngeal carcinoma and the mechanism were investigated. "